SCHEMBL2159096

SCHEMBL2159096

ClC(Cl)(Cl)c1nc(-c2nc3ccccc3[nH]2)no1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 12/20 0.51
▸ RAB9A P51151 12/20 0.51
▸ ALDH1A1 P00352 12/20 0.51
▸ SMN1; SMN2 Q16637 10/20 0.51
▸ KDM4E B2RXH2 9/20 0.51
▸ HSD17B10 Q99714 6/20 0.51
▸ NPSR1 Q6W5P4 4/20 0.51
▸ PKM P14618 4/20 0.51
▸ TP53 P04637 3/20 0.51
▸ ABCB11 O95342 1/20 0.51
▸ GPR55 Q9Y2T6 1/20 0.49
▸ GAA P10253 2/20 0.46
▸ HPGD P15428 8/20 0.44
▸ PKN1 Q16512 1/20 0.43
▸ PKN2 Q16513 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30561047 0.71 NPC1 (1.00) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL172216 0.71 NPC1 (1.00) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL30634854 0.71 NPC1 (1.00) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL3634573 0.71 NR1H4 (0.57) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL1831454 0.70 NPC1 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
Water SCHEMBL9817804 0.69 NPC1 (0.95) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL30659969 0.69 NPC1 (0.69) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL1535707 0.69 NPC1 (0.69) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL30659968 0.69 NPC1 (0.69) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL2491054 0.67 KDM4E (0.67) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110183974-A1 1,2,4-OXADIAZOLE SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES AS SMO ANTAGONISTS INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2011-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183974-A1 1,2,4-OXADIAZOLE SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES AS SMO ANTAGONISTS SHH, SMO, GLI1 NPC1 2688/4885RAB9A 2234/4885ALDH1A1 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback